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ABSTRACT 
A case is reported of electrocardiographic QT prolongation that was presumbty familial in 
origin. Torsades de points developed in association with the use ofdothinepin, despite the pmscription 
of a low dose of this drug. 
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Torsades de pointes (TDP) is a life-
threatening ventricular arrhythmia which occurs 
rarely in patients receiving high doses of 
antipsychotic drugs, particularly by the parenteral 
route (Gelenberg,1998). Recently, reports of TDP 
have appeared in association with conventional 
doses of oral antipsychotic agents (Jackson et al, 
1997). TDP often occurs in a background of QT 
segment prolongation (Gelenberg, 1998). Tricyclic 
antidepressant (TCA) drugs slow cardiac 
conduction and may therefore, theoretically, 
increase the risk for TDP. In overdose, fluoxetine 
has also been reported to occasion QT 
prolongation and TDP (Graudins et al.,1997). 
We present a case of QT prolongation 
of presumably familial origin; TDP developed in 
association with the use of low dose dothiepin, a 
drug which is commonly considered to be among 
the least cardiotoxic of the conventional TCA. 
CASE REPORT 
Ms S, a 21 year old unmarried female, 
presented to a general physician with a 2 hour 
onset of chest pain. A physical examination and 
electrocardiogram (ECG) were found to be within 
normal limits. The physician noted that she had 
been receiving dothiepin (25 mg at bed time) 
since two weeks for the management of anxiety 
associated with a psychosocial stressor, and 
therefore referred her for a psychiatric review 
At the hospital, she continued to 
complain of severe, non-radiating central chest 
pain associated with giddiness. There was no 
fear, restlessness, sweating, tremors, 
hyperreflexia or other characteristics of either 
panic anxiety or a cardiac event. Her behaviour 
appeared histrionic. Except for an irrerular pulse, 
physical examination was entirely within normal 
limits. These observations appeared to confirm 
the referring physician's opinion. 
The irregular pulse however prompted 
a second ECG, and clear abnormalities became 
evident; these included classical TDP, a 
prolonged QT interval, prominent U waves and 
complex premature ventricular contractions 
(PVCs). The patient was shifted to cordiological 
care, and she subsequently recovered with 
appropriate management of TDP complication 
of the prolonged QT syndrome. It was later 
discovered that the patient's sister had died 
suddenly and of unknown causes at age 20. 
DISCUSSION 
Several different genetic mechanisms 
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have been identified in the familial transmission 
of the prolonged QT syndrome (Keating, 1996); 
therefore the diagnosis of a prolonged QT 
syndrome in this patient strongly suggests that the 
sudden, unexplained death of her sister was due 
to QT prolongation and complications thereof. 
TDP often occurs in association with QT 
prolongation. Drugs which prolong the QT interval 
may thereby increase the nsk for TDP; this may 
explain the rare occurrence of TDP in patients 
receiving psychotropic drugs, particularly when the 
drugs are administered intravenously or in high 
doses, or when the drugs are taken in overdose 
(Glenberg, 1998). Since TCA are known to slow 
cardiac conduction, dothiepin may have been the 
participating factor in the patient described in this 
report. To our knowledge, this is the first report of 
dothiepin associated with TDP; this report is further 
unusual because the dose of dothiepin used was 
low, and because dothiepin is conventionally 
considered to carry a low risk for cardiac adverse 
effects. The pre-existing familial vulnerability of 
this patient may explain why a conventionally safe 
drug precipitated a cardiac event. 
It is likely that the known intermittence of 
the clinical syndrome was responsible for the 
normal findings at the time of the first physical 
examination and ECG. Therefore, this case also 
demonstrates that psychiatrists must guard against 
assuming a functional origin of syndroms even 
when the patient has received a clean chit from a 
physician. 
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